P04.1

Newborn affected by other maternal medication

Non-billable header

P04.1 is a non-billable header code. Use one of the more specific codes below.

Inclusion terms

Includes (from P04)

  • conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
  • nonteratogenic effects of substances transmitted via placenta
  • Note: Codes from this chapter are for use on newborn records only, never on maternal records
  • Note: These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).

Excludes1

Not coded here — never report together with this code.

  • dysmorphism due to warfarin (Q86.2)
  • fetal hydantoin syndrome (Q86.1)

Excludes2

Not included here — may be reported together when both conditions exist.

  • maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
  • maternal use of drugs of addiction (P04.4-)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) (from P04)
  • endocrine, nutritional and metabolic diseases (E00-E88) (from P04)
  • injury, poisoning and certain other consequences of external causes (S00-T88) (from P04)
  • neoplasms (C00-D49) (from P04)
  • tetanus neonatorum (A33) (from P04)
  • congenital malformations (Q00-Q99) (from P04)
  • encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-) (from P04)
  • neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4) (from P04)
  • newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-) (from P04)

Code first

Sequence the underlying condition first.

  • , if applicable, withdrawal symptoms from maternal use of drugs of addiction (P96.1)
  • withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)
  • any current condition in newborn, if applicable (from P04)

Parent code

  • P04Newborn affected by noxious substances transmitted via placenta or breast milkHeader

More specific codes P04.1

  • P04.11Newborn affected by maternal antineoplastic chemotherapyBillable
  • P04.12Newborn affected by maternal cytotoxic drugsBillable
  • P04.13Newborn affected by maternal use of anticonvulsantsBillable
  • P04.14Newborn affected by maternal use of opiatesBillable
  • P04.15Newborn affected by maternal use of antidepressantsBillable
  • P04.16Newborn affected by maternal use of amphetaminesBillable
  • P04.17Newborn affected by maternal use of sedative-hypnoticsBillable
  • P04.1ANewborn affected by maternal use of anxiolyticsBillable
  • P04.18Newborn affected by other maternal medicationBillable
  • P04.19Newborn affected by maternal use of unspecified medicationBillable

Related codes

  • P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryBillable
  • P04.2Newborn affected by maternal use of tobaccoBillable
  • P04.3Newborn affected by maternal use of alcoholBillable
  • P04.4Newborn affected by maternal use of drugs of addictionHeader
  • P04.5Newborn affected by maternal use of nutritional chemical substancesBillable
  • P04.6Newborn affected by maternal exposure to environmental chemical substancesBillable
  • P04.8Newborn affected by other maternal noxious substancesHeader
  • P04.9Newborn affected by maternal noxious substance, unspecifiedBillable

Browse